Could a pill for MS slow down Alzheimer's?
NCT ID NCT06639282
Summary
This study is testing whether siponimod, an oral medication already approved for multiple sclerosis, can slow brain shrinkage in people with mild Alzheimer's disease. Over 18 months, 105 participants will take either siponimod or a placebo pill to see if the drug is safe and if it affects the rate of brain atrophy, which is linked to memory loss. The goal is to see if this repurposed drug can help control the progression of Alzheimer's.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Joseph's Hospital and Medical Center
RECRUITINGPhoenix, Arizona, 85013, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.